Asthma Biologics Clinical Pathway Report
‘Mixed-methods evaluation of an enhanced asthma biologics clinical pathway in the West Midlands UK’ has been published in the Nature Journal.
As part of a national programme funded by the NHS Accelerated Access Collaborative (AAC) Rapid Uptake Product (RUP) programme, an enhanced severe asthma pathway was implemented in Staffordshire and Stoke-on-Trent, where there is a higher than average prevalence of severe asthma, aimed at optimising patient referrals from primary care, increasing clinic capacity for MDT assessments, and expanding the use of home care and self-administration of biologics by eligible patients.
This paper reports the findings of an independent, mixed methods evaluation of the effectiveness of the pathway changes in improving patient referrals, treatment waiting times and clinical outcomes.
The report is co-authored by:
- Sarah Damery, Janet Jones and Kate Jolly at the Institute of Applied Health Research – University of Birmingham
- Elfatih Idris, Angela Cooper and Holly Minshall at Royal Stoke University Hospital – University Hospitals of North Midlands NHS Trust
- Chris Clowes at Health Innovation West Midlands.